Literature DB >> 15634890

Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.

Timothy N J Bullock1, Hideo Yagita.   

Abstract

The expansion of CD8(+) T cells in response to Ag can be characterized as either dependent or independent of CD4(+) T cells. The factors that influence this dichotomy are poorly understood but may be dependent upon the degree of inflammation associated with the Ag. Using dendritic cells derived from MHC class II-deficient mice to avoid interaction with CD4(+) T cells in vivo, we have compared the immunogenicity of peptide-pulsed dendritic cells stimulated with molecules associated with infection to those stimulated via CD40. In the absence of CD4(+) T cell help, the expansion of primary CD8(+) T cells after immunization with TNF-alpha- or poly(I:C)-stimulated dendritic cells was minimal. In comparison, LPS- or CpG-stimulated dendritic cells elicited substantial primary CD8(+) T cell responses, though not to the same magnitude generated by immunization with CD40L-stimulated dendritic cells. Remarkably, mice immunized with any stimulated dendritic cell population generated fully functional recall CD8(+) T cells without the aid of CD4(+) T cell help. The observed hierarchy of immunogenicity was closely correlated with the expression of CD70 (CD27L) on the stimulated dendritic cells, and Ab-mediated blockade of CD70 substantially prevented the CD4(+) T cell-independent expansion of primary CD8(+) T cells. These results indicate that the expression of CD70 on dendritic cells is an important determinant for helper-dependence of primary CD8(+) T cell expansion and provide an explanation for the ability of a variety of pathogens to stimulate primary CD8(+) T cell responses in the absence of CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634890     DOI: 10.4049/jimmunol.174.2.710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

3.  CD70 expression patterns in renal cell carcinoma.

Authors:  Lucia B Jilaveanu; Joshua Sznol; Saadia A Aziz; Dylan Duchen; Harriet M Kluger; Robert L Camp
Journal:  Hum Pathol       Date:  2012-03-07       Impact factor: 3.466

4.  Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.

Authors:  Roxane Lemoine; Florence Velge-Roussel; Florence Herr; Romain Felix; Hubert Nivet; Yvon Lebranchu; Christophe Baron
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

5.  Th1 and Th2 cells help CD8 T-cell responses.

Authors:  Melinda J Ekkens; Devon J Shedlock; Euihye Jung; Amy Troy; Erika L Pearce; Hao Shen; Edward J Pearce
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

6.  Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro.

Authors:  Jianping Huang; Qiong J Wang; Shicheng Yang; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunother       Date:  2011-05       Impact factor: 4.456

Review 7.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

8.  CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses.

Authors:  Katherine E Van Deusen; Rohan Rajapakse; Timothy N J Bullock
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

9.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75.

Authors:  M C Ryan; H Kostner; K A Gordon; S Duniho; M K Sutherland; C Yu; K M Kim; A Nesterova; M Anderson; J A McEarchern; C-L Law; L M Smith
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.